Sort
10,766 grants matching “checkpoint inhibitor”
RP-3: Elucidating Mechanisms of Sensitivity and Resistance to Checkpoint Blockade Therapy for Rational Multi-Drug Immunotherapy in Urothelial Cancers
$343,314Timothy An-Thy Chan · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA
RP-3: Elucidating Mechanisms of Sensitivity and Resistance to Checkpoint Blockade Therapy for Rational Multi-Drug Immunotherapy in Urothelial Cancers
$343,314Jonathan Eric Rosenberg · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Site Specific Drug Delivery with Light-responsive Conjugates for Photo-biomodulation
$343,252Youngjae You · State University Of New York At Buffalo · R01 · FY2025 · GM
Site Specific Drug Delivery with Light-responsive Conjugates for Photo-biomodulation
$343,252Youngjae You · State University Of New York At Buffalo · R01 · FY2024 · GM
Project 3
$343,215Michelle Krogsgaard · New York University School Of Medicine · P50 · FY2024 · CA
SPINK7 in allergic inflammation
$343,200Marc E. Rothenberg · Cincinnati Childrens Hosp Med Ctr · U19 · FY2016 · AI
Project 1: Imaging, pathology, and molecular biomarkers to Optimize Treatment Switching within a SMART adaptive Framework
$343,192Angela Demichele · University Of California, San Francisco · P01 · FY2023 · CA
Improvement of cellular immunotherapy during dysbiosis- Resubmission
$343,184Ruud P.m. Dings · Univ Of Arkansas For Med Scis · R01 · FY2023 · CA
Project 1: Treatment of GBM using an oncolytic HSV engineered to improve immunogenic tumor destruction
$343,160Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2023 · CA
p53 and checkpoint pathways in cancer cell repliction
$343,125University Of Virginia Charlottesville · R01 · FY2005 · CA
Targeting EphB4-ephrinB2 to decrease immunosuppression in HNSCC
$343,092Sana D Karam · University Of Colorado Denver · P50 · FY2025 · CA
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment
$342,987Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2023 · CA
Identification of natural products to treat neoplastic disease
$342,963Benjamin Nicholson · Progenra, Inc. · R43 · FY2012 · CA
Simultaneous Radiotherapy with PD-1 and IDO1 Blockade for Overcoming Immune Suppression in Glioblastoma
$342,946Derek Alan Wainwright · Northwestern University At Chicago · P50 · FY2020 · CA
Combining senescence-inducing and senolytic agents to improve melanoma therapy
$342,876Anna E Vilgelm · Ohio State University · R37 · FY2022 · CA
Signaling Mechanisms in Genome Maintenance
$342,787Marcus Smolka · Cornell University · R35 · FY2021 · GM
Pathways of Immune Evasion in Acute Myeloid Leukemia
$342,648Evan Ferguson Lind · Oregon Health & Science University · R01 · FY2023 · CA
Epigenetically Engineered Mouse Model for Lung Cancer Therapy
$342,634Lanlan Shen · Baylor College Of Medicine · R01 · FY2024 · CA
Core B: Biospecimen Repository and Processing Core
$342,571Begonya Comin-Anduix · University Of California Los Angeles · P01 · FY2023 · CA
Core B: Biospecimen Repository and Processing Core
$342,571Begonya Comin-Anduix · University Of California Los Angeles · P01 · FY2022 · CA
Targeting Endoplasmic Reticulum Stress Sensor IRE1 to Enhance Chemotherapy Sensitivity in MYC-driven breast cancer
$342,417Xi Chen · Baylor College Of Medicine · P50 · FY2021 · CA
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers
$342,355Wei R. Chen · University Of Oklahoma · R01 · FY2020 · CA
Time-keeping mechanisms of embryonic cell cycles
$342,322Stefano Di Talia · Duke University · R01 · FY2023 · GM
Site Specific Drug Delivery with Light-responsive Conjugates for Photo-biomodulation
$342,275Youngjae You · State University Of New York At Buffalo · R01 · FY2023 · GM
HPV AND ANTIGEN PRESENTING CELLS
$342,106W Martin Kast · University Of Southern California · R01 · FY2019 · CA